A model on how to obtain data from botanical practitioners

Elsas, Siegward-M.

doi:10.1016/j.yebeh.2015.07.006

Cited by 31 publications

(1 citation statement)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In Germany, such a project has been launched (Hufeland-Vademecum, http://www.hufelandgesellschaft.de/vademecum.html). The Vademecum approach may also be relevant for screening programmes for medicinal plants as potential drugs for specific diseases [25].…”

Section: Implications and Future Developmentsmentioning

confidence: 99%

Mapping Physicians’ Experiences with Medicinal Products from Whole Medical Systems: A Descriptive Analysis of the Vademecum of Anthroposophic Medicines

et al. 2020

View full text Add to dashboard Cite

Background: Therapy in whole medical systems involves a large number of medicinal products. One source of knowledge of clinical properties of such products is the experience of therapy providers. A systematic approach to documentation, assessment, and aggregation of physicians’ experiences with anthroposophic medicinal products (AMPs) has been developed: the Vademecum of Anthroposophic Medicines. Material and Methods: The Vademecum contains structured information on AMPs, including therapeutic rationale, indications, and therapy recommendations. The information is based on a 17-item questionnaire of physicians’ therapy experiences, which is peer-reviewed by an interdisciplinary editorial board. We conducted a descriptive analysis of the Vademecum, 4th edition. Results: The Vademecum comprised 799 different AMPs, used for 1,773 indications, based on 2,543 questionnaires submitted by 274 physicians from 19 countries. The 799 AMPs comprised 52.6% of all AMPs marketed in Germany in 2015–2016. The 1,773 indications corresponded to 544 different ICD-10 three-digit codes, amounting to 29.3% (n = 544/1,854) of all three-digit codes. A total of 30.6% (n = 542/1,773) of indications were supported by ≥2 questionnaires. Conclusions: The current Vademecum covers more than half of all AMPs, used for more than one fourth of all ICD-10 three-digit codes. The Vademecum approach may be relevant for medicinal products from other whole medical systems.

show abstract

Section: Implications and Future Developmentsmentioning

confidence: 99%